Loperamide Hydrochloride Capsules USP, 2 mg, liquid filled Drug Facts

Manufacturer
Dr. Reddy's Laboratories Inc. | Strides Pharma Science Limited
Effective date
2023-06-25
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:55:23

Label at a glance#

ProductLoperamide Hydrochloride
Active ingredientLOPERAMIDE HYDROCHLORIDE
Label structure17 sections

Dosage and administration

drink plenty of clear fluids to help prevent dehydration caused by diarrhea. not for use in children under 12 years of age adults and children 12 years and over: 2 softgels after the first loose stool; 1 softgel after each subsequent loose stool; but no more than 4 softgels in 24 hours

Label contents#

Full prescribing information#

SPL PRODUCT DATA ELEMENTS SECTION

SPL UNCLASSIFIED SECTION

Active Ingredient (in each capsule)

OTC - ACTIVE INGREDIENT SECTION

Loperamide Hydrochloride USP, 2 mg

Purpose

OTC - PURPOSE SECTION

Anti-diarrheal

Use

INDICATIONS & USAGE SECTION

controls symptoms of diarrhea, including Travelers' Diarrhea

Warnings

WARNINGS SECTION

Allergy alert: Do not use if you have ever had a rash or other allergic reaction to loperamide HCl

Heart alert: Taking more than directed can cause serious heart problems or death

Do not use

OTC - DO NOT USE SECTION

  • if you have bloody or black stool
  • in children under 12 years of age

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • fever
  • mucus in stool
  • a history of liver disease
  • a history of abnormal heart rhythm

Ask a doctor or pharmacist before use if you are

OTC - ASK DOCTOR/PHARMACIST SECTION

taking a prescription drug. Loperamide may interact with certain prescription drugs.

When using this product

OTC - WHEN USING SECTION

tiredness, drowsiness, or dizziness may occur. Be careful when driving or operating machinery.

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • symptoms get worse
  • diarrhea lasts for more than 2 days
  • you get abdominal swelling or bulging. These may be signs of a serious condition.

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • drink plenty of clear fluids to help prevent dehydration caused by diarrhea.
  • not for use in children under 12 years of age
  • adults and children 12 years and over: 2 softgels after the first loose stool; 1 softgel after each subsequent loose stool; but no more than 4 softgels in 24 hours

Other information

OTHER SAFETY INFORMATION

  • store at 20°-25°C (68°-77°F). Protect from Light.
  • avoid excessive heat above 40°C (104°F)
  • do not use if carton or blister unit is open or torn
  • see side panel for lot number and expiration date

Inactive ingredients

INACTIVE INGREDIENT SECTION

butylated hydroxyanisole, FD&C Blue #1, gelatin, glycerol, glyceryl mono caprylo caprate, polyoxyl 40 hydrogenated castor oil, purified water,

printing ink white-edible oil – dewaxed bleached shellac resins, propylene glycol, sodium lauryl sulphate, titanium dioxide.                         

Questions or comments?

OTC - QUESTIONS SECTION

Questions or Comments? call toll-free weekdays 9 AM to 8 PM EST at 1-888-375-3784

Distributed by:

Dr. Reddy’s Laboratories Inc.,

Princeton, NJ 08540

Made in india

**All trademarks are property of their respective owners. This product is not affiliated with the makers/owners of Imodium® A-D

THIS PRODUCT IS PACKAGED IN A CHILD-RESISTANT AND TAMPER EVIDENT PACKAGE. USE ONLY IF BLISTERS ARE INTACT.

KEEP OUTER CARTON FOR COMPLETE WARNINGS AND PRODUCT INFORMATION.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

**COMPARE TO THE ACTIVE INGREDIENT IN IMODIUM ® A-D

Loperamide Hydrochloride Capsules USP, 2 mg

Anti-Diarrheal

Suitable for adults and children 12 years and over

12 Softgels*

*each Liquid-filled capsule contains 2 mg Loperamide Hydrochloride, USP

PlaceholderPlaceholder

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
978006loperamide HCl 2 MG Oral CapsulePSN1
978006loperamide hydrochloride 2 MG Oral CapsuleSCD1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
LOPERAMIDE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
10f838ef-a72b-645d-80f8-e2255205c3b1Product name620240805

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
75907-097-12Loperamide Hydrochloride1 in 1 CARTONCAPSULE, LIQUID FILLED11
75907-097-12Loperamide Hydrochloride12 in 1 BLISTER PACKCAPSULE, LIQUID FILLED121
75907-097-24Loperamide Hydrochloride2 in 1 CARTONCAPSULE, LIQUID FILLED21
75907-097-24Loperamide Hydrochloride12 in 1 BLISTER PACKCAPSULE, LIQUID FILLED121

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
75907-097LOPERAMIDE HYDROCHLORIDE CAPSULE, LIQUID FILLED [DR. REDDY'S LABORATORIES INC.]1Current NDC, 4 package rows20230628_356d9432-d948-4b88-b297-9161b845f86b.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
75907-09775907-097-12, 75907-097-24

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A213070-001LOPERAMIDE HYDROCHLORIDELOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-11

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-11d4dbc9d85df4…
2026-10-15 13:18:302026-09A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-11c2088c7a36db…
2026-09-14 22:38:342026-08A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-1184e616aacf4f…
2026-08-18 06:07:402026-07A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-11caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-11011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-1131067a03dcf5…
2025-08-23 18:47 UTC2025-08A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-116a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-11fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-11b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-1103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-112680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-115bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-11d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-11d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-1179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-11301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-111e350fbaab3a…
2024-05-31 18:47 UTC2024-05A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-118072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-115c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-115d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-114b0b4de00fa7…
2022-03-09 01:35 UTC2022-03A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-11bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-11782e0a99824c…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-116a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-111c564ffb4f44…
2023-12-20 04:57 UTC2023-12A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-11ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-11a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-119b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-11a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-113f0d92c62455…
2023-05-13 08:27 UTC2023-05A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-11053a50430f4f…
2023-01-26 05:58 UTC2023-01A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-113bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-113a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-11f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-11e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-11cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213070-001LOPERAMIDE HYDROCHLORIDE2MGCAPSULE / ORAL2021-08-11a50c72e98297…

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
CapturedEditionApplication-productExclusivity codeExpirationSource SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A213070-001CGT2022-04-205c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A213070-001CGT2022-04-205d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A213070-001CGT2022-04-204b0b4de00fa7…
2022-03-09 01:35 UTC2022-03A213070-001CGT2022-04-20bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A213070-001CGT2022-04-20782e0a99824c…
2023-01-26 05:58 UTC2023-01A213070-001CGT2022-04-203bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A213070-001CGT2022-04-203a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A213070-001CGT2022-04-20f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A213070-001CGT2022-04-20e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A213070-001CGT2022-04-20cb3db0bc1861…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Loperamide HydrochlorideLOPERAMIDE HYDROCHLORIDEDr. Reddy's Laboratories Inc.356d9432-d948-4b88-b297-9161b845f86b2023-06-25WarningsExact identifier
ndc (package): 75907-097-12
ndc (package): 75907-097-24
ndc (product): 75907-097
ndc11 (package): 75907009724
ndc11 (package): 75907009712
spl id: cefb1fd9-768f-c7a4-b9b1-ab7faaa67308
spl set id: 356d9432-d948-4b88-b297-9161b845f86b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.